Humacyte Receives U.S. Patent Covering Symvess and Other Bioengineered Tissues
Humacyte says a newly issued U.S. patent covers Symvess and other bioengineered tissues.
Related stories
Seatrium Contract Valued at Over S$200M
M impact | EQUITY | Oct 30, 2026, 12:39 AM UTC
Timberland Bancorp Q4 Profit Rises From Prior Quarter, Raises Dividend
M impact | EQUITY | Oct 30, 2026, 12:37 AM UTC
Semirara Mining Reports Q3 Revenue of 12.64 Billion Pesos
M impact | EQUITY | Oct 30, 2026, 12:37 AM UTC
FOXO Seeks Voting Control of Ludwig Enterprises With 74.9% Stake
FOXO Technologies reported it may beneficially own 74.9% of Ludwig Enterprises’ common stock through a proposed preferred-stock purchase and voting agreements.
L impact | EQUITY | Oct 30, 2026, 12:37 AM UTC
Ibiden Shares Fall 15% in Tokyo
M impact | EQUITY | Oct 30, 2026, 12:34 AM UTC
KOSPI Nears Risk of Falling Below 5,700
The report says the KOSPI is at risk of slipping below 5,700, citing Alphabet’s 13% plunge.
M impact | EQUITY | Oct 30, 2026, 12:34 AM UTC